AssureRx Health, a neuropsychiatric personalized medicine company, has formed a scientific advisory board, which will guide the company's R&D efforts on pharmacogenomic products.
The advisory board members include:David Mrazek, pediatrics and psychiatry professor at the Mayo Clinic; Brian Athey, associate director of the Michigan Institute for Clinical Health Research; Tracy Glauser, associate director of clinical, translational, outcomes and health services research at the Cincinnati Children's Research Foundation; James Kennedy, director of neuroscience research at the Tanenbaum Center for Pharmacogenetics, University of Toronto; Lawrence Lesko, director of the Center for Pharmacometrics and Systems Pharmacology, University of Florida College of Pharmacy; John Pestian, professor of pediatrics and computer science at the University of Cincinnati; Sheldon Preskorn, professor in the psychiatry and behavioral science department at the University of Kansas School of Medicine; and Wolfgang Sadee, chair of the department of pharmacology at the Ohio State University School of Medicine.